PMID- 18223356 OWN - NLM STAT- MEDLINE DCOM- 20080327 LR - 20220331 IS - 1075-2765 (Print) IS - 1075-2765 (Linking) VI - 15 IP - 1 DP - 2008 Jan-Feb TI - Lycopene in cancer prevention and treatment. PG - 66-81 LID - 10.1097/MJT.0b013e31804c7120 [doi] AB - Dietary intake of lycopene is inversely associated with the risk of many cancers. Preclinical studies show that lycopene has potent in vitro and in vivo antitumor effects, suggesting potential preventive and therapeutic roles for the compound. However, clinical trials with lycopene have only recently been started, and available clinical data preclude firm conclusions with regard to its use in cancer prevention and treatment. Further mechanistic studies and randomized controlled clinical intervention trials with lycopene involving cancer patients are warranted. FAU - Seren, Soley AU - Seren S AD - Department of Internal Medicine, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan 48201, USA. FAU - Lieberman, Ronald AU - Lieberman R FAU - Bayraktar, Ulas D AU - Bayraktar UD FAU - Heath, Elisabeth AU - Heath E FAU - Sahin, Kazim AU - Sahin K FAU - Andic, Fundagul AU - Andic F FAU - Kucuk, Omer AU - Kucuk O LA - eng PT - Journal Article PT - Review PL - United States TA - Am J Ther JT - American journal of therapeutics JID - 9441347 RN - 0 (Anticarcinogenic Agents) RN - 36-88-4 (Carotenoids) RN - SB0N2N0WV6 (Lycopene) SB - IM MH - Animals MH - Anticarcinogenic Agents/*pharmacology/therapeutic use MH - Carotenoids/*pharmacology/therapeutic use MH - Clinical Trials as Topic MH - Diet MH - Drug Evaluation, Preclinical MH - Humans MH - Lycopene MH - Neoplasms/*drug therapy/prevention & control RF - 169 EDAT- 2008/01/29 09:00 MHDA- 2008/03/28 09:00 CRDT- 2008/01/29 09:00 PHST- 2008/01/29 09:00 [pubmed] PHST- 2008/03/28 09:00 [medline] PHST- 2008/01/29 09:00 [entrez] AID - 00045391-200801000-00012 [pii] AID - 10.1097/MJT.0b013e31804c7120 [doi] PST - ppublish SO - Am J Ther. 2008 Jan-Feb;15(1):66-81. doi: 10.1097/MJT.0b013e31804c7120.